TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CISEN

Infectious DiseaseCardiovascularGastroenterology
Generics

CISEN is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology. Key products include ESOMEPRAZOLE MAGNESIUM.

2020
Since
1
Drugs
-
Trials
30
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

ESOMEPRAZOLE MAGNESIUM 2025-04-15
ESOMEPRAZOLE MAGNESIUM 2025-04-15
ESOMEPRAZOLE MAGNESIUM 2025-03-05
ESOMEPRAZOLE MAGNESIUM 2025-03-05
ESOMEPRAZOLE MAGNESIUM 2025-01-07
ESOMEPRAZOLE MAGNESIUM 2024-12-10
Labeling
ESOMEPRAZOLE MAGNESIUM 2024-12-10
Labeling
ESOMEPRAZOLE MAGNESIUM 2024-12-10
Labeling
ESOMEPRAZOLE MAGNESIUM 2024-12-10
Labeling
ESOMEPRAZOLE MAGNESIUM 2024-12-10
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Gastroenterology 33%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease